Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism-Reference-Cited by-同舟云学术

Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism

Published:2017-09 Issue:11 Volume:20 Page:2556-2564
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Li Ni,Johnson David C.,Weinhold Niels,Kimber Scott,Dobbins Sara E.,Mitchell Jonathan S.,Kinnersley Ben,Sud Amit,Law Philip J.,Orlando Giulia,Scales Matthew,Wardell Christopher P.,Försti Asta,Hoang Phuc H.,Went Molly,Holroyd Amy,Hariri Fadi,Pastinen Tomi,Meissner Tobias,Goldschmidt Hartmut,Hemminki Kari,Morgan Gareth J.,Kaiser Martin,Houlston Richard S.

Funder

Myeloma UK

Bloodwise

Cancer Research UK

Bobby Moore Fund

Rosetrees Trust

Dietmar Hopp Foundation

German Ministry of Education and Science

Dietmar Hopp Stiftung

German Cancer Aid

German Research Council

Multiple Myeloma Research Foundation

Heinz Nixdorf Foundation

German Center for Neurodegenerative Disorders

CIHR

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference30 articles.

1. Familial risks and temporal incidence trends of multiple myeloma;Altieri;Eur. J. Cancer,2006

2. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response;Bertolotti;Nat. Cell Biol.,2000

3. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk;Broderick;Nat. Genet.,2011

4. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing;Chubb;J. Clin. Oncol.,2015

5. Interim Analysis Of The Mmrf Commpass Trial, a Longitudinal Study In Multiple Myeloma Relating Clinical Outcomes To Genomic and Immunophenotypic Profiles;Craig;Blood,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the genetics and mechanisms of predisposition to multiple myeloma;Nature Communications;2024-08-05

2. SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments;Current Oncology;2023-08-27

3. Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling;International Journal of Molecular Sciences;2023-03-15

4. Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study;American Journal of Hematology;2023-01

5. Functional dissection of inherited non-coding variation influencing multiple myeloma risk;Nature Communications;2022-01-10